Abstract
Facial telangiectasias represent the major aesthetic alterations of several chronic inflammatory disorders arising on facial skin. We herein report on relevant clinical results of a new subtype of intense pulsed light treatments, the so-called rhodamine intense pulsed light (r-IPL), in comparison with conventional IPL (c-IPL) treatments on forty-five patients affected by facial telangiectasias. The aim of this study is to determinate whether r-IPL represents an effective and safe treatment for the most common superficial vascular alterations and could be advised as a first choice therapy for facial telangiectasias.
Acknowledgment
The authors thank Ing. Tiziano Zingoni, for the precious technical assistance in the preparation of the article and for digital drawings of the tables and figures.
Declaration of interest
The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.